Obagi Medical Launches Mineral Sunscreen for Sensitive Skin
Event summary
- Obagi Medical, part of Waldencast plc, launched Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 on April 30, 2026.
- The mineral sunscreen is designed for sensitive and post-procedure skin, featuring ceramides, squalane, and antioxidants.
- Priced at $65, the product is available on Obagi.com, Amazon.com, and through authorized providers.
- Obagi Medical claims it is the fastest-growing professional skincare brand in the U.S. as of 2024.
The big picture
Obagi Medical's launch of a mineral sunscreen aligns with the growing consumer preference for skincare-first protection. As part of Waldencast plc, Obagi benefits from operational scale and market responsiveness, positioning it to capitalize on trends in sensitive skin care. The product's focus on post-procedure skin health underscores the brand's commitment to medical-grade solutions.
What we're watching
- Market Response
- How the new sunscreen will perform in a competitive market dominated by mineral-based formulas.
- Consumer Preference
- Whether Obagi can sustain demand for high-performance, skincare-first SPF solutions.
- Strategic Expansion
- The pace at which Obagi Medical will introduce additional products targeting sensitive skin.